BeStock  
Stocks › Biotechnology › AURA

Aura Biosciences AURA

US equityMarket cap rank #3369Biotechnology
$6.87 −$0.11 (-1.58%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.77 -1.46%
Open$6.51
Prev close$6.98
Day range$6.51 – $6.98
Volume791.1K
Market cap$714.99M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$35.06M-25.6% YoY
Net profit-$32.07M-22.7% YoY
Diluted EPS-$0.29+27.5% YoY
Free cash flow-$26.52M-31.4% YoY
Operating cash flow-$26.44M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-25.8MDec '24$-27.5MMar '25$-27.0MJun '25$-26.1MSep '25$-25.6MDec '25$-33.7MMar '26$-45.6MJun '26$-32.1MSep '26

Diluted EPS by quarter

-0.52Dec '24-0.55Mar '25-0.47Jun '25-0.40Sep '25-0.37Dec '25-0.50Mar '26-0.48Jun '26-0.29Sep '26

Free cash flow by quarter

$-24.3MDec '24$-23.5MMar '25$-20.8MJun '25$-20.2MSep '25$-20.6MDec '25$-30.0MMar '26$-32.5MJun '26$-26.5MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-61.7%
Return on assets-53.5%
Return on invested capital-59.3%
Current ratio14.21
Liabilities / assets10.6%
Cash & investments$297.23M
Total debt$12.85M
Net cash (debt)$284.38M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $35.06M $48.07M $34.87M $112.79M $27.24M
Selling and Admin Expenses $10.32M $17.32M $6.91M $22.49M $5.34M
-General & Admin Expense $10.32M $17.32M $6.91M $22.49M $5.34M
Research & Development $24.74M $30.75M $27.96M $90.30M $21.90M
Operating Profit -$35.06M -$48.07M -$34.87M -$112.79M -$27.24M
Net Non-Operating Interest Income (Expense) $3.02M $2.31M $1.19M $6.63M $1.54M
Non-Operating Interest Income $3.02M $2.31M $1.19M $6.63M $1.54M
Other Income (Expense) $17,000.00 $154,000.00 $2,000.00 $77,000.00 $149,000.00
Other Non-Operating Income (Expenses) $17,000.00 $154,000.00 $2,000.00 $77,000.00 $149,000.00
Pretax Profit -$32.03M -$45.61M -$33.67M -$106.08M -$25.54M
Tax $38,000.00 $29,000.00 $11,000.00 $108,000.00 $15,000.00
Net Profit -$32.07M -$45.64M -$33.69M -$106.19M -$25.56M
Profit from Continuing Operations -$32.07M -$45.64M -$33.69M -$106.19M -$25.56M
Net Income to Parent Company -$32.07M -$45.64M -$33.69M -$106.19M -$25.56M
Net Income to Common Stockholders -$32.07M -$45.64M -$33.69M -$106.19M -$25.56M
Basic EPS -$0.29 -$0.48 -$0.50 -$1.76 -$0.37
Diluted EPS -$0.29 -$0.48 -$0.50 -$1.76 -$0.37

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $321.62M $348.13M $137.68M $169.43M $169.43M
Total Current Assets $303.10M $329.03M $118.50M $149.74M $149.74M
Cash and Cash Equivalents & Short-Term Investments $297.23M $323.84M $114.73M $144.24M $144.24M
-Cash and Cash Equivalents $41.67M $67.84M $84.79M $59.52M $59.52M
-Short Term Investments $255.56M $256.00M $29.94M $84.73M $84.73M
Receivables $1.87M $1.76M – – –
-Accrued Interest Receivable $1.87M $1.76M – – –
Prepaid Assets $3.14M $2.61M $2.71M $4.32M $4.32M
Other Current Assets $851,000.00 $819,000.00 $1.06M $1.18M $1.18M
Total Non-Current Assets $18.52M $19.10M $19.17M $19.69M $19.69M
Net PPE $16.58M $17.19M $17.89M $18.45M $18.45M
-Gross PPE $24.40M $24.77M $25.21M $25.50M $25.50M
-Accumulated Depreciation -$7.82M -$7.57M -$7.33M -$7.05M -$7.05M
Other Non-Current Assets $1.94M $1.91M $1.29M $1.24M $1.24M
Total Liabilities $34.19M $32.86M $30.43M $32.52M $32.52M
Total Current Liabilities $21.34M $19.56M $16.71M $18.38M $18.38M
Payables $1.72M $2.25M $2.57M $1.55M $1.55M
-Accounts Payable $1.72M $2.25M $2.57M $1.55M $1.55M
Current Accrued Expenses $8.31M $8.50M $7.90M $7.34M $7.34M
Short-Term Debt and Capital Lease Obligation $3.32M $3.29M $3.27M $3.24M $3.24M
-Current Capital Lease Obligation $3.32M $3.29M $3.27M $3.24M $3.24M
Other Current Liabilities $146,000.00 $908,000.00 $378,000.00 $242,000.00 $242,000.00
Total Non-Current Liabilities $12.85M $13.30M $13.72M $14.13M $14.13M
Long Term Debt and Capital Lease Obligation $12.85M $13.30M $13.72M $14.13M $14.13M
-Long Term Capital Lease Obligation $12.85M $13.30M $13.72M $14.13M $14.13M
Total Equity $287.43M $315.27M $107.25M $136.91M $136.91M
Stockholders' Equity $287.43M $315.27M $107.25M $136.91M $136.91M
Capital Stock $1,000.00 $1,000.00 $0.00 $0.00 $0.00
-Common Stock $1,000.00 $1,000.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $919.90M $914.77M $621.56M $617.43M $617.43M
Retained Earnings -$591.81M -$559.74M -$514.10M -$480.42M -$480.42M
Less: Treasury Stock -$39.09M -$39.09M – – –
Gains/Losses Not Affecting Retained Earnings -$1.57M -$670,000.00 -$207,000.00 -$102,000.00 -$102,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$26.44M -$32.50M -$29.89M -$84.74M -$20.47M
Net cash flow from continuing operations -$26.44M -$32.50M -$29.89M -$84.74M -$20.47M
Net Income from Continuing Operations -$32.07M -$45.64M -$33.69M -$106.19M -$25.56M
Depreciation & Depletion & Amortization $251,000.00 $260,000.00 $274,000.00 $1.13M $272,000.00
Other Non-Cash Items $432,000.00 $442,000.00 $412,000.00 $1.58M $402,000.00
Change in Working Capital $630,000.00 $406,000.00 -$426,000.00 $5.97M $1.56M
-Change in Prepaid Assets -$677,000.00 -$1.42M $1.73M $4.03M $2.68M
-Change in Payables and Accrued Expense $1.76M $2.84M -$1.72M $3.29M -$554,000.00
-Change in Other Current Assets -$28,000.00 -$622,000.00 -$46,000.00 $47,000.00 -$194,000.00
-Change in Other Current Liabilities -$425,000.00 -$397,000.00 -$386,000.00 -$1.39M -$377,000.00
Net cash flow from investing $114,000.00 -$226.04M $54.90M $35.60M $29.82M
Net Cash Flow from Continuing Investing Activities $114,000.00 -$226.04M $54.90M $35.60M $29.82M
Net PPE Purchase and Sale -$80,000.00 -$21,000.00 -$102,000.00 -$447,000.00 -$176,000.00
Net Investment Purchase and Sale $194,000.00 -$226.01M $55.00M $36.04M $30.00M
Financing Cash Flow $206,000.00 $241.75M $300,000.00 $77.16M $2.77M
Net Cash Flow from Continuing Financing Activities $206,000.00 $241.75M $300,000.00 $77.16M $2.77M
Net Common Stock Issuance -$123,000.00 – – $52.57M $2.77M
Proceeds from Stock Option Exercised $329,000.00 $21.34M $300,000.00 $24.58M $0.00
Ending Cash Balance $42.44M $68.60M $85.56M $60.28M $60.28M
Net Change in Cash -$26.12M -$16.78M $25.31M $28.01M $12.12M
Beginning Cash Balance $68.60M $85.56M $60.28M $32.46M $48.32M
Effect of Exchange Rate Changes -$47,000.00 -$173,000.00 -$27,000.00 -$186,000.00 -$160,000.00
Free Cash Flow -$26.52M -$32.52M -$30.00M -$85.19M -$20.65M

Discussion

No comments yet — be the first to weigh in on AURA.

Sign in to join the discussion.

Scroll to Top